We are live on ! Find out more
ALT icon

Altimmune
ALT

110 hedge funds and large institutions have $467M invested in Altimmune in 2022 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

647% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $1.75M

600% more funds holding in top 10

Funds holding in top 10: 1 → 7 (+6)

125% more capital invested

Capital invested by funds: $207M → $467M (+$260M)

27% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 30

14.47% more ownership

Funds ownership: 77.86% → 92.33% (+14%)

7% more funds holding

Funds holding: 103 → 110 (+7)

13% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 31

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
1.85%
Holding in Top 10
7
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+600%
% of All Funds
0.12%
New
38
Increased
27
Reduced
31
Closed
30
Calls
$13.1M
Puts
$1.75M
Net Calls
+$11.4M
Net Calls Change
+$6.91M

Top Buyers

1
CAM
Cormorant Asset Management
Massachusetts
+$18.5M
2
TCM
Tang Capital Management
California
+$6.33M
3
BBA
Baker Bros. Advisors
New York
+$6.19M
4
DCM
Driehaus Capital Management
Illinois
+$5.8M
5
IC
Ikarian Capital
Texas
+$5.53M

Top Sellers

1
BlackRock
BlackRock
New York
-$12.2M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$4.92M
3
State Street
State Street
Massachusetts
-$3.43M
4
VA
VR Adviser
New York
-$2.41M
5
WP
Woodline Partners
California
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
76
Corton Capital
Ontario, Canada
$209K +$110K +17,875 New
Charles Schwab
77
Charles Schwab
California
$203K -$536K -86,948 -83%
CA
78
Cetera Advisors
Colorado
$200K -$8.63K -1,400 -8%
LP
79
LMR Partners
United Kingdom
$165K +$87.2K +14,139 New
EMG
80
ETF Managers Group
New Jersey
$161K +$9.87K +1,601 +13%
SG Americas Securities
81
SG Americas Securities
New York
$158K +$83.2K +13,487 New
TI
82
Telemetry Investments
New York
$152K +$80.2K +13,000 New
ERIM
83
Eagle Ridge Investment Management
Connecticut
$121K +$64K +10,373 New
KWMG
84
King Wealth Management Group
Florida
$117K +$61.7K +10,000 New
Royal Bank of Canada
85
Royal Bank of Canada
Ontario, Canada
$97K +$35.1K +5,699 +220%
Osaic Holdings
86
Osaic Holdings
Arizona
$96K +$50.7K +8,226 +137,100%
Wells Fargo
87
Wells Fargo
California
$76K -$32.5K -5,262 -45%
TRCT
88
Tower Research Capital (TRC)
New York
$71K -$72.7K -11,787 -66%
AF
89
Advisornet Financial
Minnesota
$71K – – –
FIA
90
FNY Investment Advisers
New York
$31K +$16.8K +2,730 New
US Bancorp
91
US Bancorp
Minnesota
$23K +$5.5K +891 +82%
BCV
92
Banque Cantonale Vaudoise
Switzerland
$18K – – –
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
$13.4K -$47.4K -7,691 -87%
Fidelity Investments
94
Fidelity Investments
Massachusetts
$9K +$1.76K +285 +56%
GGI
95
Godsey & Gibb Inc
Virginia
$7K +$3.77K +611 New
UBS Group
96
UBS Group
Switzerland
$6K -$9.25K -1,500 -75%
PA
97
Parallel Advisors
California
$5K +$2.38K +386 +715%
PNC Financial Services Group
98
PNC Financial Services Group
Pennsylvania
$4K – – –
New York State Common Retirement Fund
99
New York State Common Retirement Fund
New York
$3K -$132K -21,349 -99%
Fifth Third Bancorp
100
Fifth Third Bancorp
Ohio
$3K – – –
2 3
4
5 6

ALT Hedge Fund Activity: Q2 2022 in Review

110 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2022, worth a combined $467M — up 125% from $207M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ALT positions and 30 closed out — a net gain of 8 holders — while 27 added to existing stakes and 31 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $18.5M. The largest seller was BlackRock, cutting an estimated $12.2M.

  • 110 institutional investors held Altimmune (ALT) as of Q2 2022, up from 103 in Q1 2022.
  • Funds reported $467M of Altimmune stock for Q2 2022, up 125% quarter-over-quarter.
  • 38 funds opened new Altimmune positions in Q2 2022 and 30 closed out, a net change of +8 holders.
  • The largest Altimmune buyer in Q2 2022 was Cormorant Asset Management, an estimated $18.5M added.
  • The largest Altimmune seller in Q2 2022 was BlackRock, an estimated $12.2M sold.

Based on aggregated 13F filings for Q2 2022.